News | November 18, 2016

TranS1 Recognized As A Leading Innovator In Colorado

Denver-based medical device company received accolades from three top business organizations for its 2016 accomplishments

TranS1 recently announced that it earned recognition for its efforts in innovation, leadership, and the advancement of new technologies in Colorado from three leading business organizations.

  • Winner, Most Innovative Workplace in Denver – TranS1 was recognized at the 80/95 Awards, sponsored by the Denver Post, as the most innovative workplace in Denver. The 80/95 Awards were presented during Millennial Weekend Denver and showcase companies that have millennial leaders who make an impact on culture, enterprise, and society.
  • Finalist, Apex Awards – TranS1 was named a finalist for the Colorado Technology Association’s Apex Awards. The Apex Awards recognize Colorado technology excellence, highlighting remarkable leaders and innovators.
  • Honoree, Top 250 Private Companies in Colorado – TranS1 was named one of the Top 250 Private Companies in Colorado by ColoradoBiz Magazine. The awards recognize the top 250 private companies in the state by revenue.

“TranS1’s mission is to develop breakthrough medical innovations, therefore, it is an honor to be recognized by 80/95, Colorado Technology Association, and ColoradoBiz Magazine as a leading innovator in Colorado,” said Jeff Schell, president and CEO of TranS1. “The strong talent base and business community in Denver are crucial factors in our success.”

TranS1 established operations in Denver in February 2015. The company offers technologies that solve spinal pathologies, including the AxiaLIF system, which has been on the market for a decade. TranS1 released a suite of new products in October 2016. Among those products are an MIS Pedicle Screw System, a TLIF/PLIF IBF System, and a Cervical Interbody System. Also in October, the company announced plans to launch the Capital Bone Graft Harvester and Pylon Graft Delivery system in 2017.

“I am proud of our team’s accomplishments in 2016, and with more than 10 new technologies in our pipeline, including multiple proprietary innovations poised to launch, 2017 will prove to be an even bigger year,” Schell explained.

About TranS1

TranS1 develops medical breakthroughs to solve spinal pathologies that minimize trauma to the tissues surrounding the spine. The company’s flagship product, AxiaLIF+, is a minimally invasive option for surgeons to accomplish spinal fusion at the L5-S1 joint. For more information, visit